Larose Ventures Ltd.: Larose Ventures Closes Financing and Announces Management Changes
Vancouver, British Columbia (Newsfile Corp. - April 23, 2021) - Larose Ventures Ltd. (the
Company ) announces that it has closed a non-brokered private placement, in which it raised gross proceeds of $100,000.
This placement consisted of 1,000,000 common shares of the Company at a price of ten cents per common share (the
Offering ). No finder s fees were payable in connection with the Offering. The Company intends to use the proceeds of the Offering for general working capital purposes.
The Company further announces that Harvey McKenzie and Neil Novak have been appointed as directors of the Company. In addition, Balu Gopalakrishnan has been appointed CFO and Michael Lerner has been appointed CEO.
Larose Ventures Ltd : Larose Announces Approval and Closing of Plan of Arrangement
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
PsyGen Industries Ltd : Psygen Industries Ltd and Larose Ventures Ltd Announce Reverse Takeover Transaction of 1290442 B C Ltd by Psygen Industries Ltd and Brokered Financing Led by Eight Capital and Canaccord
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
Larose Ventures Ltd.: Larose Ventures Announces Completion of Amalgamation with 1282454 B.C. Ltd.
Company or
Larose ), is pleased to announce that further to its news release dated January 22, 2021, the Company has completed its previously announced amalgamation with 1282454 B.C. Ltd. (
1282454 BC ) (the
Amalgamation ).
Pursuant to the terms of the Amalgamation, Larose and 1282454 BC have amalgamated and continued as one company (
Amalco ) pursuant to the provisions of Section 269 of the
Business Corporations Act (British Columbia) (
BCBCA ). Upon completion of the Amalgamation, all Larose common shares outstanding immediately prior to the Amalgamation were exchanged for new Amalco Class A redeemable preferred shares on a one for one basis; all 2,000,000 common shares of 1282454 BC outstanding immediately prior to the Amalgamation were exchanged for new Amalco common shares on a one for one basis; and all Larose stock options currently outstanding were cancelled. Imm